Ilja Hohenfeld

Ilja Hohenfeld is an experienced clinical operations professional with a robust background in pre-clinical and clinical development within the pharmaceuticals industry. They have held various roles, including Director of Clinical Development at CUTISS AG and Global Trial Leader at Actelion. Ilja earned a Ph.D. from the Max-Planck Institute for Molecular Physiology in Dortmund and a Master’s degree in Chemistry from Technische Universität Dortmund. With a strong track record in both early and late-stage clinical operations, Ilja thrives in cross-functional, multi-cultural settings.